Product Overview

Forxiga 5mg is a prescription medication that contains the active ingredient dapagliflozin. It belongs to a class of drugs known as sodium‑glucose cotransporter‑2 (SGLT2) inhibitors. Manufactured by AstraZeneca Pharma India Ltd, this product is formulated for the management of type 2 diabetes mellitus. Each strip contains 14 tablets, and the medication is also available in pack sizes of 28, 56, and 84 tablets to suit varying treatment durations.

What is Forxiga 5mg (Dapagliflozin)

Forxiga 5mg is the brand name for the compound dapagliflozin, a selective inhibitor of the SGLT2 protein found in the proximal renal tubules of the kidney. By blocking this transporter, dapagliflozin reduces the reabsorption of glucose, allowing excess glucose to be excreted in the urine. This mechanism helps lower blood glucose levels in adults with type 2 diabetes when used alongside diet and exercise. The drug is marketed by AstraZeneca Pharma India Ltd and is regulated by the U.S. Food and Drug Administration and equivalent authorities in other regions.

Uses and Benefits

The primary indication for Forxiga 5mg is the improvement of glycemic control in adults with type 2 diabetes mellitus. Clinical studies have demonstrated that the medication not only lowers fasting plasma glucose but also provides modest reductions in body weight and systolic blood pressure. These additional cardiovascular benefits make it a valuable option for patients who have coexisting heart disease or who are at risk for renal complications. The tablet is taken once daily, with or without food, and can be used as monotherapy or in combination with other antidiabetic agents such as metformin or insulin.

How It Works

Dapagliflozin acts by selectively inhibiting the SGLT2 transporter, which is responsible for reabsorbing approximately 90 % of filtered glucose back into the bloodstream. When this transporter is blocked, glucose is excreted through urine, leading to a decrease in circulating glucose concentrations. The resulting osmotic diuresis also contributes to modest reductions in blood pressure and body weight. The pharmacodynamic profile of dapagliflozin is characterized by a half‑life of about 12–14 hours, allowing once‑daily dosing with consistent therapeutic effect throughout the day.

Dosage Guidelines

The recommended starting dose of Forxiga 5mg is one tablet taken orally once daily, preferably at the same time each day. The dose may be adjusted based on renal function; patients with an estimated glomerular filtration rate (eGFR) below 60 mL/min/1.73 m² should consult their healthcare provider before initiating therapy. For patients with advanced chronic kidney disease (eGFR <30 mL/min/1.73 m²), the use of Forxiga is not recommended. It is essential to follow the dosage instructions provided by the prescribing clinician and to avoid exceeding the recommended dose. Adjustments are not required for elderly patients unless accompanied by renal impairment.

Side Effects

Like all medications, Forxiga 5mg may cause adverse effects. The most commonly reported side effects include genital mycotic infections, urinary tract infections, and increased urination. Less frequent but clinically important adverse events comprise ketoacidosis, dehydration, and hypoglycemia when used in combination with insulin or sulfonylureas. Patients should be advised to monitor for signs of infection, maintain adequate hydration, and report any persistent or severe symptoms to their healthcare provider. The National Institutes of Health (NIH) provides detailed safety information in its drug fact sheets.

Warnings and Precautions

Patients should inform their physician of any history of kidney disease, liver disease, or prior episodes of low blood sugar before starting Forxiga. The medication is contraindicated in individuals with a history of hypersensitivity to dapagliflozin or any of its excipients. It is also not recommended for use in patients with type 1 diabetes or in those with a history of diabetic ketoacidosis. Adequate fluid intake is advised to reduce the risk of dehydration, especially in hot weather or during vigorous exercise. Pregnant or breastfeeding women should avoid this medication unless a clinician determines that the benefits outweigh the potential risks.

Frequently Asked Questions

What is the typical dosing schedule for Forxiga 5mg?

Forxiga 5mg is taken once daily, at the same time each day, with or without food. The tablet should be swallowed whole and not crushed or split. Dose adjustments are based on kidney function and should be guided by a healthcare professional.

Can Forxiga be used together with other diabetes medications?

Yes, Forxiga can be prescribed alongside metformin, sulfonylureas, or insulin, but the dosage of the accompanying medication may need adjustment to minimize the risk of hypoglycemia. Always consult your prescribing clinician before combining therapies.

Is Forxiga safe for patients with heart failure?

Clinical trials have shown that dapagliflozin can reduce the risk of hospitalization for heart failure in patients with type 2 diabetes. However, its use in patients with severe renal impairment is limited, and a thorough evaluation by a healthcare provider is required.

What should I do if I miss a dose?

If you miss a dose, take it as soon as you remember, provided there is at least a 12‑hour interval before the next scheduled dose. If it is almost time for the next dose, skip the missed dose and resume your regular schedule. Do not double the dose to catch up.

Are there any dietary restrictions while taking Forxiga?

No specific dietary restrictions are required. However, maintaining a balanced diet and regular physical activity can enhance glycemic control and overall health. Staying well‑hydrated is advisable to support kidney function.

Related Products

• Esomeprazole 40 mg (Generic)
• Esomeprazole 20mg (Generic)
• Neksium (Esomeprazole)
• Neksium 20mg (Esomeprazole)
• Neksium 40 mg (Esomeprazole)
• Okamet 500 Mg (Metformin)
• Imdur (Isosorbide Mononitrate)
• Imdur 30 mg (Isosorbide Mononitrate)
• Imdur 60 mg (Isosorbide Mononitrate)
• Isosorbide Mononitrate Prolonged Release 60 mg (Generic)
• Isosorbide Mononitrate Prolonged Release 30 mg (Generic)
• Ticagrelor (Generic)